Waldenstrom macroglobulinemia: genetics dictates clinical course

Blood. 2014 May 1;123(18):2750-1. doi: 10.1182/blood-2014-03-558973.

Abstract

In this issue of Blood, Treon and colleagues provide strong evidence that mutations in MYD88 and CXCR4 dictate clinical presentation and survival in Waldenström macroglobulinemia (WM).

Publication types

  • Comment

MeSH terms

  • Female
  • Humans
  • Male
  • Mutation*
  • Myeloid Differentiation Factor 88 / genetics*
  • Receptors, CXCR4 / genetics*
  • Waldenstrom Macroglobulinemia / genetics*

Substances

  • Myeloid Differentiation Factor 88
  • Receptors, CXCR4